Hidenobu Suzuki

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Comparison of treatment retention between risperidone long-acting injection, paliperidone palmitate, and aripiprazole once-monthly in elderly patients with schizophrenia.

Comparison of treatment retention between risperidone long-acting injection, paliperidone palmitate, and aripiprazole once-monthly in elderly patients with schizophrenia.

Journal: Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society

Published: August 30, 2021

Continuation rate for asenapine and brexpiprazole treatment in elderly patients with schizophrenia.

Continuation rate for asenapine and brexpiprazole treatment in elderly patients with schizophrenia.

Journal: Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society

Published: August 11, 2021

Characteristics of patients who were able to switch from benzodiazepine hypnotics to lemborexant.

Characteristics of patients who were able to switch from benzodiazepine hypnotics to lemborexant.

Journal: SAGE open medicine

Published: May 12, 2021

The effect of lemborexant for insomnia disorder.

The effect of lemborexant for insomnia disorder.

Journal: SAGE open medicine

Published: April 26, 2021

Continuation rate for asenapine and brexpiprazole treatment in patients with schizophrenia.

Continuation rate for asenapine and brexpiprazole treatment in patients with schizophrenia.

Journal: Brain and behavior

Published: November 08, 2020

Benefit of extending the dosing interval of long-acting injection in maintenance treatment of outpatients with schizophrenia.

Benefit of extending the dosing interval of long-acting injection in maintenance treatment of outpatients with schizophrenia.

Journal: Asian journal of psychiatry

Published: November 29, 2019

The effect of aripiprazole once-monthly 300 mg in maintenance therapy for schizophrenia.

The effect of aripiprazole once-monthly 300 mg in maintenance therapy for schizophrenia.

Journal: Asian journal of psychiatry

Published: October 15, 2019

Comparisons of the effects of long-acting injectable monotherapy and combination therapy of long-acting injectable treatment with oral antipsychotics on treatment retention in patients with chronic schizophrenia.

Comparisons of the effects of long-acting injectable monotherapy and combination therapy of long-acting injectable treatment with oral antipsychotics on treatment retention in patients with chronic schizophrenia.

Journal: Asian journal of psychiatry

Published: December 11, 2018

Mortality rate is associated with aripiprazole once-monthly and oral asenapine administration.

Mortality rate is associated with aripiprazole once-monthly and oral asenapine administration.

Journal: Asian journal of psychiatry

Published: November 11, 2018

Treatment Continuation of 3 Second-Generation Antipsychotic Long-Acting Injections, and Oral Paliperidone in Patients With Schizophrenia for 2 Years.

Treatment Continuation of 3 Second-Generation Antipsychotic Long-Acting Injections, and Oral Paliperidone in Patients With Schizophrenia for 2 Years.

Journal: Journal of clinical psychopharmacology

Published: October 19, 2018

Mortality rate is associated with paliperidone palmitate, risperidone long-acting injection, and oral paliperidone administration.

Mortality rate is associated with paliperidone palmitate, risperidone long-acting injection, and oral paliperidone administration.

Journal: Asian journal of psychiatry

Published: April 18, 2018

Comparisons of the effects of second-generation antipsychotics long-acting injections on treatment retention according to severity of patient condition.

Comparisons of the effects of second-generation antipsychotics long-acting injections on treatment retention according to severity of patient condition.

Journal: Asian journal of psychiatry

Published: April 18, 2018

Showing 1-12 of 51

Last Updated: 09/26/2026